J Biol Chem, Vol. 274, Issue 33, 23119-23127, August 13, 1999
1 Integrin Binds the 16-kDa Subunit of Vacuolar
H+-ATPase at a Site Important for Human Papillomavirus E5
and Platelet-derived Growth Factor Signaling*
Mhairi A.
Skinner
and
Alan G.
Wildeman§
From the Department of Molecular Biology and Genetics, University
of Guelph, Guelph, Ontario N1G 2W1, Canada
 |
ABSTRACT |
Integrins mediate adhesive interactions between
cells and the extracellular matrix, and play a role in cell migration,
proliferation, differentiation, cytoskeletal organization, and signal
transduction. We have identified an interaction between the
1 integrin and the 16-kDa subunit of vacuolar
H+-ATPase (16K). This interaction was first isolated in a
yeast two-hybrid screen and confirmed by coimmunoprecipitation and in in vitro binding assays using bacterially expressed
proteins. Immunofluorescent studies performed in L6 myoblasts
expressing both native and epitope-tagged 16K demonstrate
co-localization with
1 integrin in focal adhesions.
Deletion of the fourth of four transmembrane helices in 16K results in
loss of interaction with
1 integrin in vitro
and in the two-hybrid system, and less prominent staining in focal
adhesions. This helix is also required for ligand-independent
activation of platelet-derived growth factor-
receptor signaling by
the human papillomavirus E5 oncoprotein. Overexpression of 16K or
expression of 16K lacking this helix alters the morphology of myoblasts
and fibroblasts, suggesting that the interaction of 16K with integrins
could be important for cell growth control. We also discuss the
possible role 16K might play in integrin movement.
 |
INTRODUCTION |
Integrins comprise the major family of cell surface receptor
proteins that interact with the extracellular matrix
(ECM)1 or with counter
receptors on adjacent cells. Integrin-ECM interactions (reviewed in
Refs. 1-3) control the adhesion and migration of cells, as well as the
transduction of signals regulating such processes as cell growth and
differentiation. Integrin receptors involved in ECM interactions
cluster at the points where stable binding to the matrix occurs,
producing "focal adhesions" to which cytoskeletal components and
signaling molecules co-localize (4, 5). Integrin
/
heterodimers
can be divided into subfamilies on the basis of their common
subunit. Those of the
1 subfamily include at least nine
different heterodimers that function primarily as receptors for
collagens, laminins, and fibronectin.
Much of the literature on integrins deals with their extracellular
interactions with ECM ligands and how cytoplasmic domains tweak
signaling pathways and influence cytoskeleton structure. However,
little is known about the mechanisms whereby they redistribute in the
cell membrane during focal adhesion formation; how they shuttle through
the cell during synthesis, endocytosis, and transcytosis; and how they
become targeted for degradation or recycling. It is believed that
interactions within the plasma and organellar membranes are critical to
these processes (6). Several types of integral plasma membrane proteins
have been demonstrated by co-immunoprecipitation to interact with
integrin heterodimers. These are the integrin-associated proteins,
which interact with certain
v integrin heterodimers (7),
EMMPRIN (8), and members of the four transmembrane domain (TM4) protein
family: CD9, CD53, CD63, CD81, CD82, and NAG-2, which have been shown
to complex with the
3
1 integrin (9-11).
Little is known about the functional consequences of interactions with
these proteins, although integrin-mediated Ca2+ influx has
been shown to be regulated by integrin-associated proteins (12).
Signaling from integrins and from transmembrane receptor tyrosine
kinases can converge in the focal adhesion (13). For example, binding
of growth factor PDGF-B causes dimerization of the
form of its
receptor (PDGF-
receptor), leading to the activation of the
receptor's kinase activity and autophosphorylation. PDGF-B stimulation
mimics many signaling responses triggered by integrin adhesion, such as
phosphorylation of focal adhesion kinase, paxillin, and
mitogen-activated protein kinases ERK-1 and ERK-2 (14, 15). The
convergence of integrin and PDGF-
receptor functions is supported by
data showing that fibronectin, collagen, or anti-integrin IgG binding
to fibroblasts leads to phosphorylation of the receptor in the absence
of PDGF (16).
The vacuolar H+-ATPase (V-ATPase) is a large multisubunit
enzyme present in intracellular membrane compartments such as
endosomes, lysosomes, clathrin-coated vesicles, and the Golgi complex,
where it plays a vital role in the maintenance of endocytic and
exocytic pathways (17-21). One of its subunits, a 16-kDa protein (16K)
also known as ductin, has been found in the plasma membrane of renal and kidney epithelial cells, macrophages, and some tumor cell lines
(22-25). 16K is composed of four hydrophobic regions thought to form
transmembrane
-helices, and plays a key role in the assembly and
function of the V-ATPase pump (26). In addition, it comprises structures independently of the V-ATPase, including gap junctional complexes and mediatophores, which are involved in the release of
neurotransmitters (27-30). 16K also forms a complex with the E5
oncoprotein of papillomaviruses (31, 32) and has been proposed to
mediate the ability of E5 to cause ligand-independent activation of the
PDGF-
receptor (33).
We report here the identification of an interaction between the
transmembrane domains of
1 integrin and 16K. The
interaction was detected using a yeast two-hybrid screen, and confirmed
by various in vitro and in vivo binding assays.
We find the distribution of 16K within cells to be
ECM-dependent, and show that perturbation of 16K expression
can affect the morphology of cells. These and other data in the
literature showing a requirement for transmembrane domains for proper
integrin distribution (e.g. Ref. 34) led us to hypothesize
that 16K utilizes transmembrane interactions with receptors to shuttle
them through the cell and to cell membranes.
 |
EXPERIMENTAL PROCEDURES |
Two-hybrid Plasmids--
1 integrin bait plasmids
were made by amplifying from the full-length cDNA of the bovine
1 subunit (35) sequences encoding amino acids 691-773
(transmembrane and intracellular domains, TRIC), 691-741
(transmembrane domain, TR), and 725-773 (intracellular domain, IC).
These domains are 100% homologous to mouse and human proteins. The TR
primers were 5'-TAGAATTCACTGTTCATGTTGTAGAG-3' (TR upstream) and
5'-TAGTCGACCTGGCAAATTCCCTTCTGTC-3' (TR downstream), the TRIC primers
were the TR upstream primer and 5'-TAGTCGACCTCATACTTCGGATTAAC-3' (IC
downstream), and the IC primers were 5'-TAGAATTCCTGCTGATTTGGAAG-3' (IC
upstream) and the IC downstream primer. The
5 integrin
bait plasmid was made by amplifying from the bovine
5
cDNA (35) sequences encoding amino acids 341-385, which includes
the transmembrane domain, using primers
5'-TAGAATTCGCCACAGCTGTGCAGTGG-3' (
5 upstream) and
5'-TAGTCGACTTTGAAGAAGAAGAGA-3' (
5 downstream). The PCR
products were directionally cloned into pBTM116, creating the LexA
fusion bait plasmids
1-TR,
1-TRIC,
1-IC, and
5-TR. A day 9.5/10.5 mouse
embryo cDNA library constructed in pVP16 (36) was co-transfected with the bait plasmids into the yeast strain L40 (37) using a lithium
acetate protocol (38). Data base searches were done using the BLAST
server at the NCBI (39).
Western Blot Analysis of Bait Protein Expression in
Yeast--
Yeast carrying the bait plasmids were grown to
A600 = 0.7, harvested by centrifugation, and
cells from 1.5 ml of culture were resuspended in 50 µl of Laemmli
sample buffer, frozen at
80 °C, rapidly lysed in a boiling water
bath for 5 min, then spun briefly to remove debris. Protein lysates
were fractionated on 15% SDS-polyacrylamide gels, transferred to
nitrocellulose, and probed with rabbit anti-LexA polyclonal antibody
(gift from Erica Golemis). Detection was with alkaline
phosphatase-conjugated goat anti-rabbit secondary antibody.
Cell Lines and Culture--
The rat myogenic cell line, L6
described by Yaffe (40), the rat embryo fibroblast cell line (Ref52)
and the human pancreatic tumor cell line Capan-2 were obtained from the
American Type Culture Collection. L6 and Ref52 cells were cultured at
37 °C in a 5% CO2 atmosphere in
-modified minimal
essential medium (
-MEM), supplemented with 10% fetal bovine serum.
Capan-2 cells were grown in McCoy's 5a medium with 10% fetal bovine serum.
Antibodies--
The rabbit polyclonal anti-HA antibody (Y-11)
was purchased from Santa Cruz Biotechnology. Anti-16K-M and anti-16K-N
are rabbit polyclonal antibodies raised against N-terminal peptides
from rat 16K and were used in immunoprecipitations and
immunofluorescence, respectively (41, 42). JHSL32 is a rabbit
polyclonal antibody raised against the 70-kDa subunit of V-ATPase (43).
Monoclonal Armenian hamster anti-mouse
1 integrin
(HM
1-1) was obtained from PharMingen. For double labeling
experiments, primary antibodies were visualized using fluorescein
isothiocyanate-conjugated mouse anti-hamster IgG (PharMingen), followed
by fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Sigma),
or Texas red-conjugated goat anti-rabbit IgG antibody (Molecular
Probes). Alkaline phosphatase-conjugated rabbit anti-mouse IgG
secondary antibody was from Sigma.
In Vitro Binding Assays--
Transmembrane and cytoplasmic
integrin segments were synthesized as tripartite fusions with GST and a
fragment of protein A by cloning appropriate PCR-amplified products
into the BamHI and EcoRI sites of pAGEX-2T (44).
Such an approach with protein A tagging has previously been used in
in vitro binding assays (45). The 116-amino acid protein A
tag (14 kDa) provides solubility and a uniformly sized larger carrier
for the small protein domains that vary in size from 3 to 10 kDa and
have different charges and hydrophobicities, thereby minimizing
artifacts in binding assays. The TRIC fragment was amplified
using 5'-ATCGGATCCGCCACTGTTGTAGAGAC-3' and
5-CTAGAATTCCCTCATACTTCGGATT-3', the transmembrane region using 5'-CGGATCCATTATTCCAATTGTAG-3' and 5'-CGGAATTCCCAAATCAGCAGCAAT-3', and
the cytoplasmic region using 5'-CGGGATCCAAGCTTTTAATGA-3' and 5'-CTAGAATTCCCTCATACTTCGGATT-3'. These fusions were coupled to glutathione-agarose beads, and the protein A-tagged
1
moiety released by cleavage with thrombin. EGTA was added to 5 mM, and the beads with GST removed by centrifugation. The
protein A-tagged integrin fragments were incubated with
glutathione-agarose beads to which were coupled GST fusion proteins of
full-length (GST-16K) or truncated versions (GST-TM1 and GST-TM4) of
16K. All GST fusion proteins were expressed using pGEX-5X-3. GST-16K
was made using primers (5'-ACGCGGATCCACATGGCTGACATCAAG-3' and
5'-CCGGAATTCCTACTTTGTGGAGAG-3'; 16K upstream and downstream,
respectively) tagged with BamHI and EcoRI sites
to PCR-amplify the full-length cDNA, GST-TM1 was isolated as a
BamHI-EcoRI fragment from the two-hybrid isolate
in pVP16, and GST-TM4 was amplified from the full-length cDNA using
the 16K upstream primer and an internal downstream primer
(5'-CCGGAATTCCTACACGAACAGTCGAGGC-3'; TM4 downstream). For
in vitro binding assays, 2 µg of GST-16K, GST-TM1, or
GST-TM4 protein coupled to beads were incubated at 4 °C with 2 µg
of soluble protA-TRIC, protA-TR only, or protA-IC only, for 1 h
with gentle shaking in 40 mM Hepes, pH 7.9, 100 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, 0.5% Nonidet P-40, 1% milk powder. The
beads were recovered by centrifugation and washed five times in binding
buffer without milk powder. Beads were then suspended in sample buffer,
heated, and the samples loaded onto 10% SDS-polyacrylamide gels. The
proteins were transferred to nitrocellulose and protein A fusions
detected directly by standard Western blot analysis using the rabbit
anti-mouse alkaline phosphatase-conjugated antibody.
Immunoprecipitations--
Cells grown as monolayers were chilled
to 4 °C, washed with cold PBS and lysed in cold RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS,
50 mM Tris, pH 7.5) for 30 min. They were then scraped from
the dishes with a rubber policeman, transferred to a microcentrifuge
tube, and spun for 10 min at 4 °C. The soluble protein was divided
into 25-µg aliquots to which anti-16K-M, rabbit control serum, or
HM
1-1 was added. After 1 h at 4 °C, protein A-Sepharose (20 µl of 50% slurry/ml) was added and the incubation continued for 30 min. Complexes were recovered by centrifugation, washed three times
with PBS, and run on 10% SDS-polyacrylamide gel electrophoresis under
reducing conditions. Western blot analysis was performed using HM
1-1
primary antibody, mouse anti-hamster secondary antibody, and alkaline
phosphatase-conjugated rabbit anti-mouse antibody for detection.
Metabolic Labeling of Cells--
Cells grown in 35-mm culture
dishes were starved of methionine for 20 min in
-MEM free of
methionine and serum. Following this period, 100 µCi of
[35S]methionine was added and cells were labeled at
37 °C for 8 h. The supernatant was removed, cells were washed
with 1 ml of ice-cold PBS, and harvested with a rubber policeman. Cells
were collected by gentle centrifugation at 3000 rpm for 5 min, lysed in
200 µl of RIPA buffer on ice for 10-15 min, and centrifuged at high
speed for 2 min. The supernatants were collected into a clean tube, and
40 µl was used in each immunoprecipitation. Immunoprecipitations were
performed as described above, and complexes were run on a 10%
SDS-polyacrylamide gel. Following electrophoresis, the gel was fixed in
10% acetic acid and 40% methanol for 30 min, transferred to Amplify
solution (Amersham Pharmacia Biotech), and treated for 30 min. The gel
was dried and exposed to X-AR film (Eastman Kodak Co.).
Epitope Tagging and Transfections--
The HA-epitope
(YPYDVPDYA) from the influenza virus hemagglutinin protein HA1 (46) was
added, along with a SacII restriction site, to the N
terminus of both 16K and TM4 by PCR amplification using an upstream
primer encoding the epitope,
5'-TCCCCGCGGATGTACCCCTACGACGTGCCCGACTACGCCGCTGACATCAAGAACAACCCCGAA-3', and the downstream primers used to make GST-16K and GST-TM4.
Initially, SacII-EcoRI fragments from these PCR
products were cloned into pTRE and expressed with the tet-On system
(CLONTECH). In later experiments we switched to
using the pXJ40-KK0 vector, which enables consistent high levels of
expression from an SV40 promoter, by amplifying the tagged full-length
or TM4 fragments with terminal EcoRI and BamHI
sites to allow insertion into this vector. The effects of 16K and TM4
on cell morphology were seen with both pTRE and pXJ40-KKO systems, but
the latter proved to be a more reliable vector. Stable cell lines were
made by cotransfecting vector plasmids with the hygromycin B resistance
plasmid pTK-hyg (CLONTECH), using the calcium
phosphate procedure, and selecting for colonies that grew in 200 µg/ml hygromycin.
Cell Culture Immunohistochemistry--
Cells were grown on glass
coverslips in dishes, media was removed and cells were washed twice
with PBS. Cells were fixed with 4% paraformaldehyde in PBS, washed
three times with PBS, and permeabilized by incubation with 0.1% Triton
X-100 for 30 min. They were again washed three times in PBS, then
blocked in 10% rabbit serum in PBS. Primary antibody was diluted
according to suppliers recommendations in 2% rabbit serum and
incubated with cells for 1 h, followed by one wash with PBS, and
incubation with secondary antibody for 30 min at room temperature. For
double-labeling experiments this procedure was then repeated for the
other primary and secondary antibodies, after which the cells received
three 10-min washes in PBS. They were then covered with mounting
medium, affixed to glass slides, and viewed using a Bio-Rad MRC-600
laser scanning confocal microscope equipped with a krypton-argon mixed
gas laser. Cells treated with preimmune rabbit serum instead of primary
antibodies, or untransfected control cells treated with anti-HA
antibody, served as negative controls. Single-labeling experiments in
which the secondary antibodies were mismatched with the primary
antibodies demonstrated that there was no cross-reactivity between
antibodies in the double-labeling experiments.
Bead Binding Assays--
Polystyrene latex beads (Sigma) were
coated with fibronectin, polylysine, and bovine serum albumin as
described by Grinnell and Geiger (47). Approximately 3 × 106 polystyrene latex beads (11.9 µm diameter) were
incubated for 1 h at 22 °C in 0.5 ml of
-MEM containing 25 µg of human plasma fibronectin (Sigma), 50 µg of polylysine
(Sigma), or 50 µg of bovine serum albumin. Bead binding assays were
performed according to the procedure of Burbelo et al. (48).
Cells were incubated with 25 µg/ml cycloheximide (Sigma) in
fibronectin-depleted serum. After 2 h cells were washed twice with
PBS, then detached with 0.05% trypsin and 25 µg/ml cycloheximide.
Cells (1 × 105) were subsequently plated on
coverslips for 60 min at 37 °C in
-MEM containing 25 µg/ml
cycloheximide. Each type of bead (approximately 2 × 106) was incubated with cells at 37 °C for 20 min. Cells
were then fixed and stained with anti-16K antibody as described above.
Controls in which primary antibody was replaced with preimmune serum
showed no immunofluorescence.
 |
RESULTS |
1 Integrin Interacts with 16K--
The TRIC bait
for the two hybrid screen comprised the transmembrane domain of
1 integrin, flanked by 16 amino acids on the extracellular side and the full intracellular cytoplasmic domain (Fig.
1A). This was done to avoid
using only a short highly hydrophobic bait. Nine
his+lacZ+ clones that did not react with the
control lexA-lamin bait or with the empty BTM116 plasmid were obtained
from screening 2 × 106 transformants, all encoding
proteins that interacted with this bait and the
1-TR
bait, but not the
1-IC bait consisting of the
intracellular domain flanked by only four transmembrane residues. In
addition, none of these proteins interacted with a bait containing the
transmembrane domain of the
5 integrin subunit.
Expression of both the
5 and
1
transmembrane (TR) bait proteins in yeast was similar, as detected by
an anti-LexA antibody (Fig. 1A), but none of the proteins
interacted with the
5 bait. Thus, the lack of an
interaction between 16K and
5-TR was not simply due to poor expression of that bait protein, and the interaction with the
1 transmembrane domain was not due solely to a
nonspecific interaction of hydrophobic helices. Three of the cDNA
clones recovered in this two hybrid screen encoded overlapping segments
of the 16-kDa (16K) subunit of V-ATPase (Fig. 1C), two
contained identical regions of an uncharacterized human cDNA,
KIAA0025, previously isolated from a human immature myeloid cell line
(49), one encoded a fragment of a sugar transport protein (50), and
three did not share homology with any data base entries. All contained
hydrophobic regions.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
Interacting 16K cDNA clones isolated in
the yeast two-hybrid screen. A, the
transmembrane-spanning regions of 1 and 5
integrins, from which the bait proteins were constructed, are shown at
the top. The dotted lines below each
sequence indicate the residues included in each of the baits. The
inset shows a Western blot of yeast cell extracts prepared
from cells expressing the 1-TRIC, 1-TR,
and 5-TR fragments. The blot was probed with anti-LexA
antibody, and two independent transformants are shown for each of the
three baits indicated. B, representative membrane filters on
which yeast cells were screened for two-hybrid interactions between
1 fragments and several different 16K partners. The
full-length 16K protein, an original isolate from the two-hybrid screen
that lacks the first transmembrane helix (TM1), and a mutant
lacking the fourth transmembrane helix (TM4) were made as
fusions with the VP16 activation domain and screened with the various
bait fusion proteins indicated at the periphery around each circle.
Negative controls included transformation of these plasmids alone
(no bait plasmid), with the bait plasmid (empty bait
plasmid) or with an irrelevant protein (lamin). No
growth on selective media was seen in these controls. The VP16 fusion
proteins were also tested for their abilities to interact with the
1-TRIC, 1-TR, and 1-IC
fragments. C, the full-length reading frame of 16K (155 amino acids) is shown as an open box at the top.
The graph is a hydropathy plot (Kyte and Doolittle), showing four
hydrophobic membrane-spanning regions, TM1 to TM4. The three
non-identical but overlapping regions of 16K that interacted uniquely
with the TRIC and TR baits, but not the IC bait are shown as
black bars above the graph, with their N-terminal
amino acid indicated, and the number of base pairs downstream of the
stop codon shown at the right.
|
|
Of the clones identified, 16K has several known functions that were
intriguing with respect to potential involvement with integrins. The
V-ATPases are responsible for acidification of vesicles, which
determines whether receptor-ligand complexes are degraded or recycled
(19, 21). Additionally, the 16K subunit can independently of the ATPase
form gap junctions (30).
All of the two hybrid isolates of 16K were missing the first
transmembrane domain, proteins we refer to as TM1. A representative filter of the two hybrid assay showing the interaction of one of the
three TM1 isolates with the
1-TR and
1-TRIC baits is shown in Fig. 1B
(center). To confirm that the absence of the first
transmembrane helix or some part of the 3'-nontranslated region in
these clones was not creating an artifact in the screen, we expressed
the full-length 16K coding region in the prey plasmid pVP16 and found
it to also interact specifically with the
1-TRIC and
1-TR baits, and not the
1-IC bait (Fig.
1B, left). Andresson et al. (33)
reported that the last helix of 16K, TM4, was required for its
interaction with the E5 protein of bovine papillomavirus. To determine
whether the interaction with
1 integrin also required this helix, we constructed a TM4 deletion mutant of 16K in pVP16, and
found that it was no longer able to interact with any of the baits in a
two-hybrid assay (Fig. 1B, right). When we tested
the full-length 16K, TM1, and TM4 proteins with the
5-TR
bait, none were found to interact, and filters with no colonies were
obtained, identical to that seen when TM4 was tested.
In Vitro Binding Assays--
GST fusion proteins of full-length
16K, or the mutants lacking TM1 or TM4, were produced in bacteria,
coupled to glutathione-agarose beads and assessed for their ability to
bind fragments of
1 integrin. The original TRIC bait,
the transmembrane domain alone (TR only), or the cytoplasmic domain
alone (IC only) were synthesized as tripartite fusions with GST and a
fragment of protein A, using the pAGEX2T vector (Fig.
2). Cleavage of these fusions with
thrombin released soluble protein A-tagged proteins (protA-TRIC,
protA-TR only, protA-IC only). The protein A moiety allows for direct
detection with antibody conjugates, thus eliminating the need for
different primary antibodies specific for each integrin fragment, and
thereby enabling quantitative comparison of the abilities of the
different fragments to bind to the protein on beads. The protein
A-tagged molecules were incubated with the beads to which equivalent
amounts (2 µg), based on Coomassie staining (lanes
11-13), of GST-TM1, full-length GST-16K, or GST-TM4 were
coupled, and complexes recovered by centrifugation. Western blot
analysis of these complexes with an antibody conjugate showed that the
TRIC fragment used in the initial two hybrid screen was able to bind
full-length 16K(GST-16K) and 16K lacking TM1 (GST-TM1) with similar
affinities (Fig. 2, lanes 3 and 4), in
both cases retaining approximately 5% of the input protA-TRIC molecule
(one quarter of the input is shown in lane 1),
even after five rounds of washing the beads. The removal of TM4
prevented binding (lane 2). Various negative
controls for the protA-TRIC binding were used, including beads carrying
no fusion protein, beads loaded with only GST, and beads loaded with a
DNA-binding protein, the transcription factor TEF-1. None of these
bound the input molecule (data not shown). Since GST-TM1 bound as
efficiently as GST-16K, and was easier to purify from bacterial cells,
it was used for subsequent experiments. The
1 transmembrane region alone was similarly able to bind GST-TM1 coupled
to beads (lane 7), whereas the intracellular region was not
(lane 10). Neither "protA-TR only" nor
"protA-IC only" bound to glutathione-agarose beads to which no
fusion protein was coupled (lanes 6 and
9). The binding assays in Fig. 2 were reproduced with at
least 10 independent preparations of the fusion proteins and negative
controls.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 2.
In vitro binding
of 1 and 16K. At the
top is shown the C-terminal TRIC segment of 1
integrin used in the two-hybrid screen, as well as two additional
fragments consisting of only the transmembrane or intracellular
regions. The lower part of the figure shows
Western blot assays used to detect whether protein A-tagged integrin
fragments were retained on glutathione beads to which 2 µg of
different GST fusions of 16K were coupled. Lanes
2-4 show binding of the 25-kDa protA-TRIC molecule to
full-length 16K (GST-16K) and to 16K lacking TM1 (GST-TM1),
but not to a mutant lacking TM4 (GST-TM4). Lanes
6 and 7 show binding of the 17-kDa "protA-TR
only" molecule to beads carrying GST-TM1 but not to beads alone
(-ve). Lanes 9 and 10 show
that the 20-kDa "protA-IC only" molecule is not able to bind to
GST-TM1. Lanes 1, 5, and 8 contain one-fourth (0.5 µg) of the soluble protA-tagged molecule used
in each of the three sets of experiments. Lanes
11, 12, and 13 show Coomassie-stained
aliquots of the GST-TM1, GST-16K, and GST-TM4 proteins used in the
assays, confirming that the amount of each protein that was used in the
binding assays was equivalent.
|
|
Coimmunoprecipitation and Co-localization of
1
Integrin and 16K--
Further evidence that
1 integrin
and 16K interact in vivo was obtained from
co-immunoprecipitation analyses, using extracts from rat L6 myoblasts.
These cells express
1 integrin and produce visible focal
adhesions (Ref. 51 and our own observations). Immunoprecipitation of
RIPA lysates with anti-16K recovered a protein that was reactive to
anti-
1 antibody, and identical in size to
immunoprecipitated
1 (Fig.
3, lanes 1 and
3). We also metabolically labeled cells with
[35S]methionine, and immunoprecipitated with anti-16K an
identically sized labeled product, which comigrated with one of the
proteins present in complexes pulled down by anti-
1
(Fig. 3, lanes 5 and 6). With
immunoprecipitations of non-labeled extracts, we detected several
molecular mass forms of
1 interacting with 16K
(lane 3). The larger of these (~160-170 kDa)
was less efficiently pulled down with our anti-
1
antibody (lane 1), which recovered primarily the
~125-kDa
1 species also seen in the radiolabeled
extracts.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 3.
Co-immunoprecipitation of
1 integrin with 16K in L6 myoblast
cells. L6 myoblasts were lysed at subconfluence, to avoid
differentiated myotubes, and 25 µg of total cellular protein were
used in immunoprecipitations with either anti- 1
(lane 1), nonspecific rabbit serum
(lane 2), or anti-16K (lane
3). Complexes recovered on protein A-Sepharose were analyzed
by Western blot using anti- 1 antibody. Metabolically
labeled cells were also used in immunoprecipitations with either
control rabbit serum (lane 4), anti-16K
(lane 5), or anti- 1 (lane
6). On reducing gels, 1 integrin migrates with a
molecular mass of approximately 125 kDa (arrow in
lane 1.
|
|
Double fluorescence labeling was used to localize
1
integrin and 16K in L6 cells and in an unrelated human pancreatic tumor cell line (Capan 2), chosen because of reports that 16K is up-regulated in human metastatic pancreatic cancer (42). Considering that 16K can be
present both as part of the V-ATPase complex and on its own in gap
junctions, it was anticipated as well that
1 would likely not co-localize to all sites where 16K is found. In agreement with this, in L6 cells 16K was found predominantly in the cytoplasm (Fig. 4A). However, a portion
localized to focal adhesions, where much of the
1
integrin (Fig. 4B) was located. The pancreatic cell line
Capan 2 also showed co-localization of
1 with 16K in the
plasma membrane, both in isolated cells (Figs.
5, B and E) and in
clusters of compacted cells that typify the growth form of this cell
line in culture (Fig. 5, A and D). The
co-localization of 16K with
1 was largely independent of
the V-ATPase, since an antibody to the enzyme's 70-kDa subunit (70K)
showed that it was largely absent from focal adhesions (Fig. 4,
C and D). Capan 2 cells showed a striking
dissimilarity in 70K staining versus that of either 16K or
1. In clumps of cells (Fig. 5C) and single cells (Fig. 5F), the 70K staining was predominantly in the
cytoplasm and absent from plasma membranes and surfaces where cell-cell contact was occurring.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 4.
Co-localization of native and epitope-tagged
full-length 16K with 1 integrin in
focal adhesions in L6 myoblasts. Cells were grown on coverslips,
fixed, and doubly labeled. All were stained for 1
integrin, using the HM 1-1 hamster monoclonal antibody, mouse
anti-hamster IgG secondary antibody, and a fluorescein
isothiocyanate-conjugated goat anti-mouse tertiary antibody. The cells
were co-stained with either rabbit anti-16K, a rabbit antibody to the
70-kDa subunit of V-ATPase (70K), or rabbit anti-HA followed by Texas
Red-conjugated goat anti-rabbit antibody. The right
column (panels B, D,
F, and H) shows 1 staining, while
the left column (A, C,
E, and G) shows the location of native 16K
(A), native 70K (C), epitope-tagged 16K
(E), and epitope-tagged TM4 mutant (G) within the
same cells. Arrows point to focal adhesions.
Scale bar = 25 µm.
|
|

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
Detection of native 16K and 70K V-ATPase
subunits in the Capan 2 pancreatic tumor cell line. Cells were
grown on coverslips, fixed, and stained as follows. Panels
A and B show 1 localization, and
panels D and E show the location of
16K in the same cells as A and B, respectively,
with double labeling carried out as in Fig. 4. Panels
C and F were stained with the rabbit anti-70-kDa
antibody and Texas Red-conjugated goat anti-rabbit secondary antibody,
and show the location of the 70K V-ATPase subunit in clumps and
individual cells, respectively. Scale bars = 20 µm.
|
|
Epitope Tagging of 16K--
The inability of the TM4 mutant to
bind
1 raised the possibility that this truncated
protein's distribution in cells might be altered. To permit
distinction of a TM4 mutant from native 16K, we generated stable L6
cell lines expressing either HA-epitope-tagged full-length or TM4
mutant proteins. Cells expressing the TM4 mutant showed variations from
typical myoblast structure, and the HA-TM4 protein (Fig. 4G)
had a more perinuclear distribution than that of epitope-tagged
full-length 16K (Fig. 4E). The HA-tagged full-length protein, but not tagged TM4 protein, showed a distribution that mirrored that of
1 integrin, similar to native untagged
16K (panel A).
1 staining revealed
that focal adhesions in the TM4-expressing cells (panel
H) were less punctate than in untransfected control cells
(panels B and D). Nevertheless, these
cells expressing TM4, when stained with anti-16K and
anti-
1, had endogenous 16K that colocalized with
1 to these structures (data not shown). These experiments showed that the fourth transmembrane helix of 16K is
important for the cellular localization of the protein in
vivo, and plays a role in defining focal adhesions.
Fibronectin-dependent Redistribution of
16K--
Although the mechanisms whereby integrins become
redistributed in the membrane are not known, the presence of integrin
ligands can lead to formation of focal adhesions (52). We used
fibronectin-coated beads to cluster integrins in L6 cells, and looked
for a concurrent redistribution of 16K. Cells were first trypsinized
and incubated with cycloheximide in fibronectin-depleted serum to
obtain an initial random dispersement of fibronectin receptors. The
binding of cells to fibronectin-coated beads then can then be used to induce redistribution of receptors to the points of contact (53). When
this experiment was done, 16K redistributed to a pool at those contact
points (Fig. 6A). Beads coated
with polylysine, a positively charged nonspecific adhesion promoting
polypeptide, bound to cells, but 16K did not localize to the contact
points (panel C). These results suggest that
insoluble fibronectin initiates redistribution of 16K by clustering and
immobilizing
1 integrin.

View larger version (102K):
[in this window]
[in a new window]
|
Fig. 6.
Fibronectin-induced redistribution of 16K in
L6 myoblasts. Cells were incubated with polystyrene latex beads
coated with fibronectin (panel A) or polylysine
(panel C), and 16K visualized using anti-16K
antibody and a Texas Red-conjugated secondary antibody.
Panels B and D are transmitted light
views of panels A and C, to show the
location of beads binding to cells. No fluorescence was observed when
the primary antibody was replaced with preimmune serum.
Arrows indicate the clustering of 16K induced by contact
with fibronectin. Scale bar = 25 µm.
|
|
Altered Morphology of L6 Myoblasts and Ref52 Cells--
The above
experiments predicted that perturbation of 16K within cells could
potentially lead to a change in cell-ECM interactions, and in this
regard it had been previously reported that the expression of a TM4
mutant of 16K in 3T3 fibroblasts led to anchorage-independent growth as
assessed by formation of colonies in soft agar (33). We used L6 and rat
embryonic fibroblast (REF52) cells to inquire whether 16K might be
involved in the regulation of cell morphology and growth (Fig.
7). Stable transfectants overexpressing
full-length 16K, or expressing the TM4 mutant, showed a change in
morphology in both cell types. L6 cells with 16K became more
spindle-shaped, and divided in such a way as to remain lined up
lengthwise. The TM4 mutant protein, in contrast, caused them to have
less well defined edges, and to show reduced effects of contact with
other cells. REF52 cells overexpressing full-length 16K became
strikingly elongated and underwent a conversion to a flattened
morphology, while maintaining long tenuous end-to-end connections.
REF52 cells expressing the TM4 mutant became shorter and broader than
control cells, with less well defined edges. The full-length REF-16K
transfectants had a doubling time approximately twice that of control
cells or REF-TM4 transfectants, a possible consequence of their highly extended shape. Thus, with both a myoblast and a fibroblast cell line,
the overexpression of wild type 16K led to an elongation of the cells,
while the TM4 mutant led to a smaller, more distorted appearance. The
conclusions from these experiments were based on three independently
isolated stable cell lines for both full-length and TM4 transfectants
in both cell types, all of which exhibited the described
phenotypes.

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 7.
L6 myoblasts and REF52 cells overexpressing
16K and TM4 mutant have an altered cellular morphology. Rat
myoblasts (L6) and rat embryo fibroblasts (REF52)
were fixed, stained with Giemsa, and photographed. L6 cells
overexpressing 16K (L6-16K) became elongated, whereas L6
cells overexpressing a protein lacking the fourth transmembrane helix
(L6-TM4) become broader, with less distinct edges and a
reduced effect of contact with other cells compared with L6 cells
transfected with the parental plasmid (L6). REF52 cells
overexpressing 16K (REF-16K) have a more elongated spindle
morphology than control REF52 cells transfected with the parental
plasmid (REF). REF52 cells overexpressing TM4 mutant 16K
(REF-TM4) become less polarized. Scale
bar = 50 µm.
|
|
 |
DISCUSSION |
Integrins, like many membrane-bound receptors, are directed after
synthesis to the cell membrane in vesicles that bud off from the
endoplasmic reticulum and cycle through the Golgi complex (54). These
vesicles emerge from the trans-Golgi and fuse with the cell membrane,
extruding the amino termini of integrin chains to the extracellular
environment. Integrins are not thought to be in this way directed to
focal adhesions, but rather to redistribute within the membrane to
those points in response to binding to an ECM ligand (4). This response
has been shown, at least with
1 and
3
integrins, to involve the cytoplasmic domain, perhaps through
interaction with a cytoskeletal component, with ligand binding
overcoming a block to directed movement (55-57).
The finding of an interaction between the 16-kDa subunit of V-ATPase
and the transmembrane domain of
1 integrin raises a number of new possibilities for how integrins move. Specifically, 16K
could be an important mediator of integrin movement via vesicles that
shuttle receptor-ligand complexes through the cell. These complexes are
engulfed in coated and non-clathrin-coated vesicles en route to
endosomes, where 16K is abundant and where the V-ATPases play a key
role in regulating acidification that leads to complex dissociation
(58-61). Our observation that fibronectin-coated beads caused 16K, and
as seen in Fig. 6B, associated vesicles, to pool at the site
where contact between the cell and the bead was made is consistent with
the hypothesis that at those points there is active engulfment and
cycling of receptors. Experiments using fibronectin-coated beads and
anti-
1 integrin-coated beads showed a strikingly similar
accumulation of
1 integrin,
-actinin, actin, talin
(53), and rho (48) in the cytoplasm adjacent to the site of attachment
to beads. It is a reasonable hypothesis that 16K is helping to direct
and stabilize
1 transmembrane interactions during the
recycling process.
Vesicles derived when clathrin is removed can also shuttle
complexes through the process of transcytosis, which
1
integrin has been observed to undergo in fibroblasts, hepatic
epithelial cells, and Chinese hamster ovary cells (62, 63). In light of
this, it is possible that focal adhesions form when integrins that are
being continuously endocytosed and recycled back to the surface of the
cell become retained only at points where they contact the ECM. The
redistribution need not involve movement through the membrane, but
rather a repetitive recycling that "finds" the points where the ECM
would allow for formation of a focal adhesion. Once integrins contact a
ligand, their half-life at that point is extended (64), and subsequent
cytoskeletal proteins of the focal adhesion aggregate. The
ligand-dependent requirement of the cytoplasmic domain of
integrins for their relocation to focal adhesions can be considered in
light of this hypothesis of integrin cycling. The need for ligand
binding could simply reflect the need to get integrins into mobile
vesicles through internalization of receptor-ligand complexes. Once
internalized only the cytoplasmic domain would protrude from these
vesicles, and through its interactions with talin, vinculin, paxillin,
-actinin, and other cytoskeletal associated proteins direct vesicle
movement along the cytoskeletal network that organizes in response to
focal adhesions.
The importance of transcytosis and integrin recycling also has
relevance to migratory cells, where it has been proposed that integrins
holding the cell to the matrix move rearwards as the cell advances,
thereby polarizing within the cell the formation and dissolution of
integrin-ligand complexes (65). Further attachments at the cell's
leading edge would require replenishments of matrix receptors to move
the cell forward. Consistent with this, it has been shown that
neutrophil migration involves endocytosis of integrins from the rear of
the cell, followed by transport through the cell and exocytosis at the
leading edge (66).
The perturbation of cell morphology observed in our full-length
and TM4 transfectants suggests a role for 16K in regulating cell-ECM
interactions. The TM4 mutant, although reportedly defective in ATPase
activity (67) and
1 binding (our data), is nevertheless able to interact with 16K (33). One interpretation is that the presence
of the TM4 mutant proteins in the ATPase interferes with the normal
acidification of endosomes and leads to greater recycling of intact
receptors to the cell membrane, thereby promoting migration and leading
to cells with shorter extensions. Bretscher (65) predicted, based on
his analysis of fibronectin receptor cycling (62), that fibroblasts
would be longer if receptor cycling were impaired. Overexpression of
native 16K led to elongation of REF52 cells, possibly because the
additional molecules caused
1 to be aberrantly retained
in the cell membrane. An impairment of endosome acidification by the
TM4 mutant is reminiscent of the observation that the E5 transmembrane
oncoprotein of papillomaviruses, which binds 16K (32), also prevents
this acidification, and leads to enhanced receptor signaling (68).
The involvement of 16K with integrins also provides an interesting link
with the observation that adhesion of fibroblasts to fibronectin leads
to alkalinization of the cytoplasm (69). The V-ATPases do not need a
counter-ion when they pump protons across membranes (70), and they are
one of the principle enzymes that can affect cellular pH. The movement
of H+ ions from the cytoplasm into acidic vesicles could be
enhanced when contact with a particular matrix component leads to
reorganization of the repertoire of receptor-ligand complexes, a
process that would necessarily involve endosome processing. Within the
V-ATPase enzyme, the membrane bound hexamer of 16K molecules, known as the V0 subunit of the enzyme, provides a docking site for
the V1 subunit that includes the 70K protein, which leads
to ATPase activity (67, 71). Immunofluorescence experiments showed that the distribution of 70K does not extend into the cell membrane to the
extent of 16K, raising the possibility that membrane 16K is playing a
role in receptor internalization, and once internalized in vesicles
could provide attachment sites for the remainder of the V-ATPase. It is
unlikely, based on the 70K staining, that all of the membrane 16K we
observe is part of a functional V-ATPase enzyme. Some of the 16K could
be serving as gap junctions.
There is additional evidence that 16K might play a role in the
membrane independently of its direct participation in V-ATPase or gap
junctions. The papillomavirus E5 oncoprotein binds both 16K and the
PDGF-
receptor (31, 32). The TM4 mutant of 16K that fails to
interact with
1 also cannot bind E5, and can cause anchorage-independent growth in 3T3 cells (33). There is strong evidence that signaling through both PDGF-
and
1
integrins converges. Both PDGF and fibronectin lead to phosphorylation
of the PDGF-
receptor itself and of focal adhesion kinase
FAK125, and to recruitment of paxillin to focal adhesions
(14). 16K coimmunoprecipitates in a trimeric complex with E5 and
PDGF-
receptor and is proposed, through its interaction with E5, to facilitate dimerization of the receptor and resulting signaling in the
absence of PDGF (72, 73). 16K is in this way implicated in
transformation by E5. Although we can only speculate at present, it is
possible that 16K mediates the reported PDGF-independent activation of
the PDGF-
receptor following
1 integrin-ligand interaction.
Recently, another integrin-binding protein, integrin-linked kinase, was
identified as binding to the cytoplasmic domain of
1 and
3 integrins, and it was reported that overexpression of integrin-linked kinase altered the morphology of intestinal epithelial cells and induced anchorage-independent growth (74, 75). These effects
are reminiscent of the effect of the 16K TM4 mutant on 3T3 fibroblasts
(33) and are consistent with our observation that TM4 alters the
morphology of adherent cells. It is possible that integrin-linked
kinase overexpression leads to its accumulation onto ligated
fibronectin receptors and disrupts their internalization and recycling.
The involvement of 16K with
1 integrin bridges cell
membrane-ECM interactions with the internal processing and trafficking of molecules. It will be of interest to determine whether 16K is in
fact involved with more than just
1 and PDGF-
receptor functions, and whether observations showing its overexpression in some cancer cells (42) and the inhibition of cell growth by an
inhibitor of V-ATPases, bafilomycin (76, 77), reflect a major role of
16K in cell growth control.
 |
ACKNOWLEDGEMENTS |
Antibodies to 16K were provided by Shoji
Ohkuma, to 70K by Stephen Gluck and L. Shannon Holliday, and to LexA by
Erica Golemis. The BTM116 vector was obtained from Paul Bartel and Stan
Fields, the mouse embryo cDNA library in VP16 from Stan Hollenberg,
the lexA-lamin control plasmid from Rolf Sternglanz, the XJ40-KK0 vector from Iain Farrance, and the full-length cDNA of 16K from Gary Dean. Assistance with confocal microscopy was provided by Melissa
Farquhar. Krassimir Yanculov and William Wong provided useful comments
on the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by the National Cancer
Institute of Canada with funds from the Terry Fox Run.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by grants from the Natural Sciences and Engineering
Research Council of Canada, Semex Canada, and the Ontario Ministry of
Agriculture and Food.
§
To whom correspondence should be addressed. Tel.: 519-824-4120 (ext. 2486); Fax: 519-837-2075; E-mail: wildeman@uoguelph.ca.
 |
ABBREVIATIONS |
The abbreviations used are:
ECM, extracellular
matrix;
PCR, polymerase chain reaction;
HA, hemagglutinin;
GST, glutathione S-transferase;
TRIC, transmembrane and
intracellular domain;
TR, transmembrane domain;
IC, intracellular
domain;
V-ATPase, vacuolar H+-ATPase;
PDGF, platelet-derived growth factor;
PBS, phosphate-buffered saline;
TM, transmembrane domain;
-MEM,
-minimum essential medium;
RIPA, radioimmune precipitation.
 |
REFERENCES |
| 1.
|
Hynes, R. O.
(1992)
Cell
69,
11-25[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Clark, E. A.,
and Brugge, J. S.
(1995)
Science
268,
233-239[Abstract/Free Full Text]
|
| 3.
|
Dedhar, S.,
and Hannigan, G. E.
(1996)
Curr. Opin. Cell Biol.
8,
657-669[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Burridge, K.,
Fath, K.,
Kelly, T.,
Nuckolls, G.,
and Turner, C.
(1988)
Annu. Rev. Cell Biol.
4,
487-525[CrossRef]
|
| 5.
|
Turner, C. E.,
and Burridge, K.
(1991)
Curr. Opin. Cell Biol.
3,
849-853[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Brown, M. S.,
Anderson, R. G.,
and Goldstein, J. L.
(1983)
Cell
32,
663-667[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Brown, E.,
Hooper, L.,
Ho, T.,
and Gresham, H.
(1990)
J. Cell Biol.
111,
2785-2794[Abstract/Free Full Text]
|
| 8.
|
Berditchevski, F.,
Chang, S.,
Bodorova, J.,
and Hemler, M. E.
(1997)
J. Biol. Chem.
272,
29174-29180[Abstract/Free Full Text]
|
| 9.
|
Berditchevski, F.,
Zutter, M. M.,
and Hemler, M. E.
(1996)
Mol. Biol. Cell
7,
193-207[Abstract]
|
| 10.
|
Tachibana, I.,
Bodorova, J.,
Berditchevski, F.,
Zutter, M. M.,
and Hemler, M. E.
(1997)
J. Biol. Chem.
272,
29181-29189[Abstract/Free Full Text]
|
| 11.
|
Rubinstein, E.,
Poindessous-Jazat, V.,
Le Naour, F.,
Billard, M.,
and Boucheix, C.
(1997)
Eur. J. Immunol.
27,
1919-1927[Medline]
[Order article via Infotrieve]
|
| 12.
|
Schwartz, M. A.,
Brown, E. J.,
and Fazeli, B.
(1993)
J. Biol. Chem.
268,
19931-19934[Abstract/Free Full Text]
|
| 13.
|
Plopper, G. E.,
McNamee, H. P.,
Dike, L. E.,
Bojanowski, K.,
and Ingber, D. E.
(1995)
Mol. Biol. Cell
6,
1349-1365[Abstract]
|
| 14.
|
Rankin, S.,
and Rozengurt, E.
(1994)
J. Biol. Chem.
269,
704-710[Abstract/Free Full Text]
|
| 15.
|
Claesson-Welsh, L.
(1994)
J. Biol. Chem.
269,
32023-32026[Free Full Text]
|
| 16.
|
Sundberg, C.,
and Rubin, K.
(1996)
J. Cell Biol.
132,
741-752[Abstract/Free Full Text]
|
| 17.
|
Forgac, M.
(1992)
J. Exp. Biol.
172,
155-169[Abstract/Free Full Text]
|
| 18.
|
Nelson, N.
(1992)
J. Exp. Biol.
172,
149-153[Abstract/Free Full Text]
|
| 19.
|
Johnson, L. S.,
Dunn, K. W.,
Pytowski, B.,
and McGraw, T. E.
(1993)
Mol. Biol. Cell
4,
1251-1266[Abstract]
|
| 20.
|
Reaves, B.,
and Banting, G.
(1994)
FEBS Lett.
345,
61-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Clague, M. J.,
Urbé, S.,
Aniento, F.,
and Gruenberg, J.
(1994)
J. Biol. Chem.
269,
21-24[Abstract/Free Full Text]
|
| 22.
|
Swallow, C. J.,
Grinstein, S.,
and Rotstein, O. D.
(1990)
J. Biol. Chem.
265,
7645-7654[Abstract/Free Full Text]
|
| 23.
|
Márquez-Sterling, N.,
Herman, I. M.,
Pesacreta, T.,
Arai, H.,
Terres, G.,
and Forgac, M.
(1991)
Eur. J. Cell Biol.
56,
19-33[Medline]
[Order article via Infotrieve]
|
| 24.
|
Gluck, S. L.,
Nelson, R. D.,
Lee, B. S.,
Wang, Z. Q.,
Guo, X. L.,
Fu, J. Y.,
and Zhang, K.
(1992)
J. Exp. Biol.
172,
219-229[Abstract/Free Full Text]
|
| 25.
|
Martinez-Zaguilan, R.,
Lynch, R. M.,
Martinez, G. M.,
and Gillies, R. J.
(1993)
Am. J. Physiol.
265,
C1015-C1029[Abstract/Free Full Text]
|
| 26.
|
Hanada, H.,
Hasebe, M.,
Moriyama, Y.,
Maeda, M.,
and Futai, M.
(1991)
Biochem. Biophys. Res. Commun.
176,
1062-1067[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Birman, S.,
Meunier, F.-M.,
Lesbats, B.,
Le Caer, J.-P.,
Rossier, J.,
and Israel, M.
(1990)
FEBS Lett.
261,
303-306[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Leitch, B.,
and Finbow, M. E.
(1990)
Exp. Cell Res.
190,
218-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Finbow, M. E.,
Goodwin, S. F.,
Meagher, L.,
Lane, N. J.,
Keen, J.,
Findlay, J. B.,
and Kaiser, K.
(1994)
J. Cell Sci.
107,
1817-1824[Abstract]
|
| 30.
|
Finbow, M. E.,
Harrison, M.,
and Jones, P.
(1995)
BioEssays
17,
247-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Goldstein, D. J.,
Finbow, M. E.,
Andresson, T.,
McLean, P.,
Smith, K.,
Bubb, V.,
and Schlegel, R.
(1991)
Nature
352,
347-349[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Goldstein, D. J.,
Andresson, T.,
Sparkowski, J. J.,
and Schlegel, R.
(1992)
EMBO J.
11,
4851-4859[Medline]
[Order article via Infotrieve]
|
| 33.
|
Andresson, T.,
Sparkowski, J.,
Goldstein, D. J.,
and Schlegel, R.
(1995)
J. Biol. Chem.
270,
6830-6837[Abstract/Free Full Text]
|
| 34.
|
Solowska, J.,
Edelman, J. M.,
Albelda, S. M.,
and Buck, C. A.
(1991)
J. Cell Biol.
114,
1079-1088[Abstract/Free Full Text]
|
| 35.
|
MacLaren, L. A.,
and Wildeman, A. G.
(1995)
Biol. Reprod.
53,
153-165[Abstract]
|
| 36.
|
Hollenberg, S. M.,
Sternglanz, R.,
Cheng, P. F.,
and Weintraub, H.
(1995)
Mol. Cell. Biol.
15,
3813-3822[Abstract]
|
| 37.
|
Vojtek, A. B.,
Hollenberg, S. M.,
and Cooper, J. A.
(1993)
Cell
74,
205-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Gietz, D.,
St. Jean, A.,
Woods, R. A.,
and Schiestl, R. H.
(1992)
Nucleic Acids Res.
20,
1425[Free Full Text]
|
| 39.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Yaffe, D.
(1968)
Proc. Natl. Acad. Sci. U. S. A.
61,
477-483[Free Full Text]
|
| 41.
|
Nezu, J.-I.,
Motojima, K.,
Tamura, H.-O.,
and Ohkuma, S.
(1992)
J. Biochem. (Tokyo)
112,
212-219[Abstract/Free Full Text]
|
| 42.
|
Ohta, T.,
Numata, M.,
Yagishita, H.,
Futagami, F.,
Tsukioka, Y.,
Kitigawa, H.,
Kayahara, M.,
Nagakawa, T.,
Miyazaki, I.,
Yamamoto, M.,
Iseki, S.,
and Ohkuma, S.
(1996)
Br. J. Cancer
73,
1511-1517[Medline]
[Order article via Infotrieve]
|
| 43.
|
Lee, B. S.,
Holliday, L. S.,
Ojikutu, B.,
Krits, I.,
and Gluck, S. L.
(1996)
Am. J. Physiol.
270,
C382-C388[Abstract/Free Full Text]
|
| 44.
|
Smith, D. B.,
Berger, L. C.,
and Wildeman, A. G.
(1993)
Nucleic Acids Res.
21,
359-360[Free Full Text]
|
| 45.
|
Berger, L. C.,
Smith, D. B.,
Davidson, I.,
Hwang, J.-J.,
Fanning, E.,
and Wildeman, A. G.
(1996)
J. Virol.
70,
1203-1212[Abstract]
|
| 46.
|
Wilson, I. A.,
Niman, H. L.,
Houghten, R. A.,
Cherenson, A. R.,
Connolly, M. L.,
and Lerner, R. A.
(1984)
Cell
37,
767-768[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Grinnell, F.,
and Geiger, B.
(1986)
Exp. Cell. Res.
162,
449-461[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Burbelo, P. D.,
Miyamoto, S.,
Utani, A.,
Brill, S.,
Yamada, K. M.,
Hall, A.,
and Yamada, Y.
(1995)
J. Biol. Chem.
270,
30919-30926[Abstract/Free Full Text]
|
| 49.
|
Nomura, N.,
Miyajima, N.,
Sazuka, T.,
Tanaka, A.,
Kawarabayasi, Y.,
Sato, S.,
Nagase, T.,
Seki, N.,
Ishikawa, K.-I.,
and Tabata, S.
(1994)
DNA Res.
1,
47-56[Free Full Text]
|
| 50.
|
Matsuo, N.,
Kawamoto, S.,
Matsubara, K.,
and Okubo, K.
(1997)
Biochem. Biophys. Res. Commun.
238,
126-129[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Bergman, M.,
Joukov, V.,
Virtanen, I.,
and Alitalo, K.
(1995)
Mol. Cell. Biol.
15,
711-722[Abstract]
|
| 52.
|
Fath, K. R.,
Edgell, C. J.,
and Burridge, K.
(1989)
J. Cell Sci.
|